<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font30">and </span>
   <span class="font20">with </span>
   <span class="font17">al., </span>
   <span class="font17">patients </span>
   <span class="font15">(). </span>
   <span class="font15">HCV </span>
   <span class="font14">for </span>
   <span class="font14">were </span>
   <span class="font14">The </span>
   <span class="font13">{background </span>
   <span class="font13">liver </span>
   <span class="font13">therapy </span>
   <span class="font13">treatment </span>
   <span class="font13">infection </span>
   <span class="font13">DAAs </span>
   <span class="font12">disease </span>
   <span class="font12">margin </span>
   <span class="font12">thalassemia </span>
   <span class="font12">{border-style </span>
   <span class="font12">genotype </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">(.%) </span>
   <span class="font12">al.. </span>
   <span class="font12">iron </span>
   <span class="font12">(%) </span>
   <span class="font11">chronic </span>
   <span class="font11">was </span>
   <span class="font11">Thalassemia </span>
   <span class="font11">are </span>
   <span class="font11">cell </span>
   <span class="font11">from </span>
   <span class="font11">not </span>
   <span class="font11">has </span>
   <span class="font11">hepatitis </span>
   <span class="font11">sickle </span>
   <span class="font11">virus </span>
   <span class="font11">after </span>
   <span class="font11">treated </span>
   <span class="font11">SVR </span>
   <span class="font11">antiviral </span>
   <span class="font11">different </span>
   <span class="font11">have </span>
   <span class="font11">major </span>
   <span class="font11">patients, </span>
   <span class="font11">study </span>
   <span class="font11">subjects </span>
   <span class="font11">this </span>
   <span class="font11">Clin. </span>
   <span class="font11">available </span>
   <span class="font11">genotypes </span>
   <span class="font11">px; </span>
   <span class="font11">ribavirin </span>
   <span class="font11">risk </span>
   <span class="font11">that </span>
   <span class="font11">viral </span>
   <span class="font11">{font-family </span>
   <span class="font10">All </span>
   <span class="font10">carcinoma </span>
   <span class="font10">days) </span>
   <span class="font10">due </span>
   <span class="font10">font-size </span>
   <span class="font10">interferon </span>
   <span class="font10">led </span>
   <span class="font10">overload </span>
   <span class="font10">according </span>
   <span class="font10">been </span>
   <span class="font10">before </span>
   <span class="font10">between </span>
   <span class="font10">blood </span>
   <span class="font10">cirrhosis </span>
   <span class="font10">data </span>
   <span class="font10">did </span>
   <span class="font10">double; </span>
   <span class="font10">efficacy </span>
   <span class="font10">eradication </span>
   <span class="font10">hepatocellular </span>
   <span class="font10">high </span>
   <span class="font10">increase </span>
   <span class="font10">new </span>
   <span class="font10">patient </span>
   <span class="font10">performed </span>
   <span class="font10">subjects), </span>
   <span class="font10">therapies </span>
   <span class="font10">transfusion </span>
   <span class="font10">weeks </span>
   <span class="font10">Agents </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Br. </span>
   <span class="font10">DFO </span>
   <span class="font10">Direct-acting </span>
   <span class="font10">Exp. </span>
   <span class="font10">Hepatitis </span>
   <span class="font10">Hepatol. </span>
   <span class="font10">Italian </span>
   <span class="font10">Liver </span>
   <span class="font10">SCD </span>
   <span class="font10">Table </span>
   <span class="font10">This </span>
   <span class="font10">affected </span>
   <span class="font10">al. </span>
   <span class="font10">all </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">can </span>
   <span class="font10">chelation </span>
   <span class="font10">clinical </span>
   <span class="font10">complexes </span>
   <span class="font10">disease. </span>
   <span class="font10">one </span>
   <span class="font10">other </span>
   <span class="font10">patients. </span>
   <span class="font10">plus </span>
   <span class="font10">regimens </span>
   <span class="font10">response </span>
   <span class="font10">solid; </span>
   <span class="font10">such </span>
   <span class="font10">these </span>
   <span class="font10">treatments </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(â€“) </span>
   <span class="font10">./j.jceh... </span>
   <span class="font10">Anal. </span>
   <span class="font10">FS, </span>
   <span class="font10">Haematol. </span>
   <span class="font10">Marco </span>
   <span class="font10">Molecular </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Origa </span>
   <span class="font10">Sickle </span>
   <span class="font10">Sofosbivir </span>
   <span class="font10">about </span>
   <span class="font10">administration </span>
   <span class="font10">alpha-a </span>
   <span class="font10">also </span>
   <span class="font10">analysis </span>
   <span class="font10">approved </span>
   <span class="font10">bold </span>
   <span class="font10">costs </span>
   <span class="font10">courier; </span>
   <span class="font10">defined </span>
   <span class="font10">disease, </span>
   <span class="font10">drugs </span>
   <span class="font10">em; </span>
   <span class="font10">had </span>
   <span class="font10">hemolytic </span>
   <span class="font10">hepatic </span>
   <span class="font10">higher </span>
   <span class="font10">induced </span>
   <span class="font10">infection. </span>
   <span class="font10">major. </span>
   <span class="font10">mortality </span>
   <span class="font10">negative </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">serum </span>
   <span class="font10">since </span>
   <span class="font10">some </span>
   <span class="font10">still </span>
   <span class="font10">study. </span>
   <span class="font10">therapy. </span>
   <span class="font10">there </span>
   <span class="font10">treat </span>
   <span class="font10">two </span>
   <span class="font10">values </span>
   <span class="font10">which </span>
   <span class="font10">years </span>
  </p>
 </body>
</html>
